4
Changes in Ownership
HAEMONETICS CORP Filed Acc 0001127602-18-028076
Director sold 30,824 shares at an average $111.83 ($3,446,909)
- Director acquired 25,122 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
GRANADILLO PEDRO P · Director
Table I: Non-derivative
8 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2018-09-17 | Exercise or conversion : show line 1 in the form | +8,196 | $36.37 | $298,089 | 41,555 | D |
| 2018-09-17 | Exercise or conversion : show line 2 in the form | +6,573 | $45.45 | $298,743 | 48,128 | D |
| 2018-09-17 | Exercise or conversion : show line 3 in the form | +10,353 | $35.50 | $367,532 | 58,481 | D |
| 2018-09-17 | Sale : show line 4 in the form | −1,502 | $108.92 | $163,598 | 56,979 | D |
| 2018-09-17 | Sale : show line 5 in the form | −3,696 | $110.11 | $406,967 | 53,283 | D |
| 2018-09-17 | Sale : show line 6 in the form | −13,183 | $111.33 | $1,467,663 | 40,100 | D |
| 2018-09-17 | Sale : show line 7 in the form | −11,812 | $113.16 | $1,336,646 | 28,288 | D |
| 2018-09-17 | Sale : show line 8 in the form | −631 | $114.16 | $72,035 | 27,657 | D |
| Open-market sales · 30,824 sh · avg $111.83 · $3,446,909 | ||||||
Table II: Derivative
3 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2018-09-17 | Exercise or conversion : show line 9 in the form Non-qualified Stock Option (Right to Buy) | −8,196 | 0 | D |
| 2018-09-17 | Exercise or conversion : show line 10 in the form Non-qualified Stock Option (Right to Buy) | −6,573 | 0 | D |
| 2018-09-17 | Exercise or conversion : show line 11 in the form Non-qualified Stock Option (Right to Buy) | −10,353 | 0 | D |
Loading xslF345X03/form4.xml…